Article

New Issue Alert: Breast Cancer Special Issue 2019

Here’s a look at what’s inside our 2019 Breast Cancer special issue.

Here’s a look at what’s inside our 2019 Breast Cancer special issue:

Most people who undergo mastectomy lose feeling in their chests. However, microsurgeons have found a way to restore sensation. Meet two women who are Feeling Like New.

Next, From One to Many. After two decades, patients with HER2-positive breast cancer have a plethora of new and emerging treatments instead of just a single agent. Our feature story explores these advancements.

And, survivors at risk of lymphedema are asked to follow a standard list of lifestyle adaptations, but some experts are Bending the Rules. Within the pages of this issue, we walk you through the steps that they’re suggesting avoid the side effect.

To read these stories and more, visit the full issue online.

Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email-profile for more information.

And, as always, thanks for reading.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.